# Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients.

> **NCT00287456** · NA · WITHDRAWN · sponsor: **University of Texas Southwestern Medical Center**

## Conditions studied

- Cystic Fibrosis Related Diabetes

## Interventions

- **DEVICE:** Insulin Pump
- **DRUG:** Insulin
- **PROCEDURE:** Oral Glucose Tolerance Test
- **PROCEDURE:** Whole body Protein Turnover

## Key facts

- **NCT ID:** NCT00287456
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-02-02
- **Primary completion:** 2006-02-02
- **Final completion:** 2006-02-02
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00287456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00287456, "Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients.". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00287456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*